Literature DB >> 12887905

Guarding the genome: electrostatic repulsion of water by DNA suppresses a potent nuclease activity of topoisomerase IB.

Ligeng Tian1, Christopher D Claeboe, Sidney M Hecht, Stewart Shuman.   

Abstract

Type IB topoisomerases cleave and rejoin DNA strands through a stable covalent DNA-(3'-phosphotyrosyl)-enzyme intermediate. The stability of the intermediate is a two-edged sword; it preserves genome integrity during supercoil relaxation, but it also reinforces the toxicity of drugs and lesions that interfere with the DNA rejoining step. Here, we identify a key determinant of the stability of the complex by showing that introduction of an Sp or Rp methylphosphonate linkage at the cleavage site transforms topoisomerase IB into a potent endonuclease. The nuclease reaction entails formation and surprisingly rapid hydrolysis of a covalent enzyme-DNA methylphosphonate intermediate. The approximately 30,000-fold acceleration in the rate of hydrolysis of a methylphosphonate versus phosphodiester suggests that repulsion of water by the DNA phosphate anion suppresses the latent nuclease function of topoisomerase IB. These findings expose an Achilles' heel of topoisomerases as guardians of the genome, and they have broad implications for understanding enzymatic phosphoryl transfer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12887905     DOI: 10.1016/s1097-2765(03)00263-6

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  19 in total

1.  Electrostatic suppression allows tyrosine site-specific recombination in the absence of a conserved catalytic arginine.

Authors:  Paul A Rowley; Aashiq H Kachroo; Chien-Hui Ma; Anna D Maciaszek; Piotr Guga; Makkuni Jayaram
Journal:  J Biol Chem       Date:  2010-05-06       Impact factor: 5.157

2.  Characterization of mimivirus DNA topoisomerase IB suggests horizontal gene transfer between eukaryal viruses and bacteria.

Authors:  Delphine Benarroch; Jean-Michel Claverie; Didier Raoult; Stewart Shuman
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

Review 3.  Probing enzyme phosphoester interactions by combining mutagenesis and chemical modification of phosphate ester oxygens.

Authors:  James T Stivers; Rajesh Nagarajan
Journal:  Chem Rev       Date:  2006-08       Impact factor: 60.622

4.  Chemical and traditional mutagenesis of vaccinia DNA topoisomerase provides insights to cleavage site recognition and transesterification chemistry.

Authors:  Lyudmila Yakovleva; Shengxi Chen; Sidney M Hecht; Stewart Shuman
Journal:  J Biol Chem       Date:  2008-03-25       Impact factor: 5.157

5.  Active site electrostatics protect genome integrity by blocking abortive hydrolysis during DNA recombination.

Authors:  Chien-Hui Ma; Paul A Rowley; Anna Macieszak; Piotr Guga; Makkuni Jayaram
Journal:  EMBO J       Date:  2009-05-14       Impact factor: 11.598

6.  Requirements for catalysis in the Cre recombinase active site.

Authors:  Bryan Gibb; Kushol Gupta; Kaushik Ghosh; Robert Sharp; James Chen; Gregory D Van Duyne
Journal:  Nucleic Acids Res       Date:  2010-05-12       Impact factor: 16.971

7.  Restoration of catalytic functions in Cre recombinase mutants by electrostatic compensation between active site and DNA substrate.

Authors:  Aashiq H Kachroo; Chien-Hui Ma; Paul A Rowley; Anna D Maciaszek; Piotr Guga; Makkuni Jayaram
Journal:  Nucleic Acids Res       Date:  2010-05-28       Impact factor: 16.971

8.  Chemical mutagenesis of vaccinia DNA topoisomerase lysine 167 provides insights to the catalysis of DNA transesterification.

Authors:  Lyudmila Yakovleva; Stewart Shuman
Journal:  Biochemistry       Date:  2013-01-23       Impact factor: 3.162

9.  3'-modified oligonucleotides by reverse DNA synthesis.

Authors:  Christopher D Claeboe; Rong Gao; Sidney M Hecht
Journal:  Nucleic Acids Res       Date:  2003-10-01       Impact factor: 16.971

10.  A functional type I topoisomerase from Pseudomonas aeruginosa.

Authors:  Teesta Jain; Benjamin J Roper; Anne Grove
Journal:  BMC Mol Biol       Date:  2009-03-24       Impact factor: 2.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.